Published Research & Citations

This study demonstrated that CJC-1295 produces dose-dependent increases in mean GH concentrations by 2-10 fold for 6 days or more and in IGF-I concentrations by 1.5-3 fold for 9-11 days with no serious adverse reactions.

Study confirmed the safety profile and sustained GH elevation with CJC-1295 administration in adults with GH deficiency, showing potential therapeutic applications.

First characterization of ipamorelin as a selective GH secretagogue with minimal effects on cortisol and prolactin, demonstrating its superior safety profile compared to other GHRPs.

Demonstrated ipamorelin's efficacy in stimulating GH release and promoting anabolic effects including increased body weight and bone mineral density.

Comprehensive study showing BPC-157's therapeutic effects on gastrointestinal healing, anastomosis recovery, and neuroprotective properties.

Early research demonstrating BPC-157's effects on sphincter function and tissue healing, establishing its therapeutic potential.

Study showing BPC-157 promotes tendon healing by enhancing growth hormone receptor expression in tendon fibroblasts, supporting its use in musculoskeletal injuries.

Demonstrated TB-500's role in promoting wound healing through enhanced cell migration, angiogenesis, and collagen deposition.

Landmark study showing TB-500 promotes cardiac repair through progenitor cell mobilization and blood vessel formation.

Phase 3 trial demonstrating tesamorelin's efficacy in reducing visceral adipose tissue by 15-18% in patients with abdominal fat accumulation.

Review of tesamorelin's mechanisms and clinical efficacy in reducing visceral fat and improving metabolic markers including triglycerides and glucose metabolism.

Study demonstrating AOD 9604's ability to reduce body fat without affecting blood glucose or IGF-1 levels, showing its selective lipolytic activity.

Landmark discovery of MOTS-c as a mitochondrial-derived peptide that regulates metabolism, improves insulin sensitivity, and enhances exercise capacity.

Review of MOTS-c's role in metabolic regulation, mitochondrial function, and potential therapeutic applications for metabolic disorders.

Research showing epithalon's ability to activate telomerase and elongate telomeres in various tissues, supporting its anti-aging potential.

Long-term study demonstrating epithalon's effects on extending lifespan, reducing tumor incidence, and improving biomarkers of aging.

Comprehensive review of GHK-Cu's multiple anti-aging mechanisms including antioxidant effects, collagen stimulation, and gene regulation.

Gene expression analysis showing GHK-Cu modulates over 4,000 genes involved in tissue repair, anti-inflammation, and antioxidant responses.

Comprehensive review of NAD+ metabolism's role in energy homeostasis, mitochondrial function, and aging.

Landmark review establishing NAD+ decline as a hallmark of aging and its therapeutic potential in age-related diseases.

Comprehensive review of Semax's nootropic effects including enhanced learning, memory, attention, and neuroprotection.

Clinical study demonstrating Semax's efficacy in treating cerebrovascular disease with neuroprotective and cognitive-enhancing effects.

Review of Selank's anxiolytic properties and mechanisms including modulation of neurotransmitter systems and stress response.